Glaxo Smithkline Consumer Nigeria PLC operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Glaxo Smithkline Consumer Nigeria PLC with three other
pharmaceutical manufacturers in Africa:
sales of 444.53 million Moroccan Dirhams [US$46.24 million]
Societe Adwya SA
(108.18 million Dinar [US$37.72 million]
of which 59%
was Pharmacy), and
Fidson Healthcare Limited
(16.23 billion Naira [US$52.91 million]
During the year ended December of 2018, sales at
Glaxo Smithkline Consumer Nigeria PLC were 18.41 billion Naira (US$60.02 million).
increase of 14.4%
versus 2017, when the company's sales were 16.09 billion Naira.
Sales of Pharmaceuticals saw an increase
15.4% in 2018, from
10.36 billion Naira to 11.95 billion Naira.